◆ Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2026-09-15
Two-year outcomes following PSMA PET and MRI guided prostate SABR with simultaneous focal boost: a brief report from the ARGOS-CLIMBER phase 1/2 trial.
Yasir Alayed, Andrew Loblaw, Lucas C Mendez, Rohann J M Correa, Aneesh Dhar, David Laidley, Andrew Warner, Hatim Fakir, Matt Wronski, John Conyngham, Zahra Kassam, Joelle Helou, David P D'Souza, Vikram Velker, Michael Lock, Belal Ahmad, Glenn S Bauman
原始摘要（英文原文）· Original abstract
ARGOS-CLIMBER is a phase 1/2 trial evaluating PSMA PET and MRI guided prostate SABR with a simultaneous boost to intraprostatic and nodal disease in men with unfavourable intermediate and high-risk prostate cancer. The updated results demonstrate acceptable safety and quality of life with high biochemical and imaging response rates.
Two-year outcomes following PSMA PET and MRI guided prostate SABR with simultaneous focal boost: a brief report from the ARGOS-CLIMBER phase 1/2 trial. — 科研速览 Science Skim